Leading global contract research organizations based on revenue 2020
In 2020, the leading contract research organizations worldwide included Laboratory Corporation of America Holdings, IQVIA, and Syneos Health, to name a few. The top company, Laboratory Corporation of America Holdings had nearly 14 billion U.S. dollars in revenue during that year. Comparatively, the second company IQVIA generated about 11.4 billion U.S. dollars in revenue.
Contract research organizations
Contract research organizations (CROs) are companies that are contracted by larger pharmaceutical companies to manage select aspects of clinical trials. Today, CROs are essential for pharmaceutical research and development. Pharmaceutical companies are spending more money than ever on research and development and there is no indication that spending will decrease in the future. Evidence suggests that CROs will become even more valuable. The clinical CRO market is expected to increase over 60 billion U.S. dollars by 2020. It is also expected that the revenue share generated by CROs in the Asian-Pacific region will further increase.
Pharmaceutical research and development
Globally, Roche and Johnson & Johnson will be the top pharmaceutical companies based on their projected research and development spending. There are regional differences in research and development among pharmaceutical companies. Of all pharmaceutical companies globally those based in the U.S. developed the most new chemical or biological entities between 2015 and 2019.
Contract research organizations
Contract research organizations (CROs) are companies that are contracted by larger pharmaceutical companies to manage select aspects of clinical trials. Today, CROs are essential for pharmaceutical research and development. Pharmaceutical companies are spending more money than ever on research and development and there is no indication that spending will decrease in the future. Evidence suggests that CROs will become even more valuable. The clinical CRO market is expected to increase over 60 billion U.S. dollars by 2020. It is also expected that the revenue share generated by CROs in the Asian-Pacific region will further increase.
Pharmaceutical research and development
Globally, Roche and Johnson & Johnson will be the top pharmaceutical companies based on their projected research and development spending. There are regional differences in research and development among pharmaceutical companies. Of all pharmaceutical companies globally those based in the U.S. developed the most new chemical or biological entities between 2015 and 2019.
